Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Hepatocellular carcinoma risk diminishes with time following HCV eradication
Among individuals with cirrhosis and cured hepatitis C virus (HCV) infection, the risk of hepatocellular carcinoma tapers off progressively through 6 years after HCV eradication, as shown in a study. However, the risk remains above thresholds that require screening.
Hepatocellular carcinoma risk diminishes with time following HCV eradication
30 Nov 2023
Mediterranean diet helps with gastrointestinal, psychological symptoms in IBS
Adopting a Mediterranean diet is feasible and may be beneficial to individuals with irritable bowel syndrome (IBS), with a study suggesting that the diet improves gastrointestinal and psychological symptoms in this population.
Mediterranean diet helps with gastrointestinal, psychological symptoms in IBS
30 Nov 2023
Endoscopic ultrasound-guided CPN effective for abdominal pain in pancreatic cancer
Endoscopic ultrasound-guided celiac plexus neurolysis added to medical management (EUS-CPN+MM) provides beneficial effects for abdominal pain in patients with unresectable pancreatic cancer at 4 and 12 weeks, reports a recent study.
Endoscopic ultrasound-guided CPN effective for abdominal pain in pancreatic cancer
29 Nov 2023
Transcutaneous neuromodulation improves symptoms in functional dyspepsia
Patients with functional dyspepsia (FD) may benefit from transcutaneous neuromodulation (TN) treatment, which can significantly improve symptoms and quality of life, according to a study.
Transcutaneous neuromodulation improves symptoms in functional dyspepsia
29 Nov 2023
Novel tri-agonist confers significant gains for MASLD patients
In a substudy of a phase II obesity trial, individuals with MASLD* and obesity benefited significantly from retatrutide, a once-weekly, injectable, novel synthetic molecule that has shown potent agonist action at GIP**, GLP-1***, and glucagon receptors.